S100A4 involvement in metastasis: Deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme

Cancer Research

Volumn 59, Issue 18, 1999, Pages 4702-4708

  Bjørnland, Kristin ^a   Winberg, Jan Olof ^b   Ødegaard, Olav Tobias ^b   Hovig, Eivind ^a   Loennechen, Thrina ^b   Aasen, Ansgar O ^a   Fodstad, Øystein ^a   Mælandsmo, Gunhild Mari ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE A; ISOPROTEIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; PROTEIN S 100; RIBOZYME; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; CYTOSKELETON; ENZYME REGULATION; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; METASTASIS; METASTASIS POTENTIAL; MOLECULAR DYNAMICS; OSTEOSARCOMA; OSTEOSARCOMA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; REGULATORY MECHANISM; RNA ANALYSIS;

BONE NEOPLASMS; COLLAGENASES; GELATINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OSTEOSARCOMA; RNA, CATALYTIC; RNA, MESSENGER; S100 PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033568527     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Fodstad, Ø., and Kjønniksen, I. Microenvironment revisited: time for reappraisal of some prevailing concepts of cancer metastasis. J. Cell. Biochem., 56: 23-28, 1994.
2. Liotta, L. A. Cancer cell invasion and metastasis. Sci. Am., 266: 54-59, 1992.
3. Price, J. P., Bonovich, M. T., and Kohn, E. The biochemistry of cancer dissemination. Crit. Rev. Biochem. Mol. Biol., 32: 175-253, 1997.
4. Duffy, P. Proteases as prognostic markers in cancer. Clin. Cancer Res., 2: 613-618, 1996.
5. Stetler-Stevenson, W. G., Hewitt, R., and Corcoran, M. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Sem. Cancer Biol., 7: 147-154, 1996.
6. Conese, M., and Blasi, F. The urokinase/urokinase-receptor system and cancer invasion. Baillieres Clin. Haematol., 8: 365-389, 1995.
7. Barraclough, R., Savin, J., Dube, S. K., and Rudlard, P. S. Molecular cloning and sequence of the gene for p9Ka. A cultured myoepithelial cell protein with strong homology to S-100, a calcium-binding protein. J. Mol. Biol., 198: 13-20, 1987.
8. 2+-binding protein family. Genes Dev., 3: 1086-1093, 1989.
9. Davies, B. R., Davies, M. P., Gibbs, F. E., Barraclough, R., and Rudland, P. S. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene. 8: 999-1008, 1993.
10. Davies, M. P., Rudland, P. S., Robertson, L., Parry, E. W., Jolicoeur, P., and Barraclough, R. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene, 13: 1631-1637, 1996.
11. Ambartsumian, N. S., Grigorian, M. S., Larsen, I. F., Karlstrøm, O. Sidenius, N. Rygaard, J. Georgiev, G., and Lukanidin E. Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene. Oncogene, 19: 1621-1630, 1996.
12. Ke, Y., Jing, C., Barraclough, R., Smith, P., Davies, M. P., and Foster, C. S. Elevated expression of calcium-binding protein p9Ka is associated with increasing malignant characteristics of rat prostate carcinoma cells. Int. J. Cancer, 71: 832-837, 1997.
13. Mælandsmo, G. M., Hovig, E., Skrede, M., Engebraaten, O., Flørenes, V. A., Myklebost, O., Grigorian, M., Lukanidin, E., Scanlon, K. J., and Fodstad, Ø. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res., 56: 5490-5498, 1996.
14. (2+)-binding proteins of the S100 family in malignant human breast cancer cell lines and biopsy samples. Int. J. Cancer, 57: 684-690, 1994.
15. Grigorian, M., Ambartsumian, N., Lykkesfeldt, A. E., Bastholm, L., Elling, F., Georgiev, G., and Lukanidin, E. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int. J. Cancer, 67: 831-841, 1996.
16. Merzak, A., Parker, C., Koochekpour, S., Sherbet, G. V., and Pilkington, G. J. Overexpression of the 18A2/mts1 gene and down-regulation of the T1MP-2 gene in invasive human glioma cell lines in vitro. Neuropathol. Appl. Neurobiol., 20: 614-619, 1994.
17. Takenaga, K., Nakansihi, H., Wada, K., Suzuki, M., Matsuzaki, O., Matsuura, A., and Endo, E. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin. Cancer Res., 3: 2309-2316, 1997.
18. Takenaga, K., Nakamura, Y., Endo, H., and Sakiyama, S. Involvement of S100-related calcium binding protein pEL98 (or mst1) in cell motility and tumor cell invasion. Jpn. J. Cancer Res., 85: 831-839, 1994.
19. Ford, H. L., Salim, M. M., Chakravarty, R., Aluiddin, V., and Zain, S. B. Expression of mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line. Oncogene, 11: 2067-2075, 1995.
20. Grigorian, M. S., Tulchinsky, E. M., Zain, S., Ebralidze, A. K., Kramerov, D. A., Kriajevska, M. V., Georgiev, G. P., and Lukanidin, E. M. The mts1 gene and control of tumor metastasis. Gene, 135: 229-238, 1993.
21. Takenaga, K., Nakamura, Y., Sakiyama, S., Hasegawa, Y., Sato, K., and Endo, H. Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin. J. Cell Biol., 124: 757-768, 1994.
22. Kriajevska, M. V., Cardenas, M. N., Grigorian, M. S., Ambartsumian, N. S., Georgiev, G. P., and Lukanidin, E. M. Non-muscle myosin heavy chain as a possible target for protein encoded by metastasis-related mts-1 gene. J. Biol. Chem., 269: 19679-19682, 1994.
23. Andersen, K., Mælandsmo, G. M., Hovig, E., Fodstad, Ø., Loennechen, T., and Winberg, J. O. Interleukin-1α and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells modulated by the metastasis associated protein CAPL. Anticancer Res., 18: 3299-3303, 1998.
24. Fodstad, Ø., Brøgger, A., Bruland, Ø., Solheim, Ø., Nesland, J., and Pihl, A. Characteristics of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma. Int. J. Cancer, 38: 33-40, 1986.
25. Feinberg, A. P., and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132: 6-13, 1983.
26. Church, G. M., and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.
27. Sambrook, J., Fritsch, E. F., and Manitis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
28. Stetler-Stevenson, W. G., Brown, P. D., Onisto, M., Levy, A. T., and Liotta, L. A. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem., 265: 13933-13938, 1990.
29. Sato, H., Takino, T., Okada, Y, Cao, J., Yamamoto, E., and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (Lond.), 370:61-65, 1994.
30. Svendsrud, D. H., Loennechen, T., and Winberg, J. O. Effect of adenosine analogues on the expression of matrix metalloproteinases and their inhibitors from human dermal fibroblasts. Biochem. Pharmacol., 53: 1511-1520, 1997.
31. Heussen, C., and Dowdle, E. B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal, Biochem., 102: 196-202, 1980.
32. Fernández-Resa, P., Mira, E., and Quesada, A. R. Enhanced detection of casein zymography of matrix metalloproteinases. Anal. Biochem., 224: 434-435, 1995.
33. Makowski, G. S., and Ramsby, M. L. Calibrating gelatin zymography with human gelatinase standards. Anal. Biochem., 236: 353-356, 1996.
34. Kleiner, D. E., and Stetler-Stevenson, W. G. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem., 218: 325-329, 1994.
35. Strongin, A. Y., Collier, I., Bannikov, G., Manner, B. I., Grant, G. A., and Goldberg, G. I. Mechanism of cell surface activation of 72 kd collagenase: isolation of the activated form of membrane metalloprotease. J. Biol. Chem., 270: 5331-5338, 1995.
36. Sato, H., and Seiki, M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J. Biochem. (Tokyo), 119: 209-215, 1996.
37. Ford, H. L., and Zain, S. Interaction of metastasis associated Mts1 protein with nonmuscle myosin. Oncogene, 10: 1597-1605, 1995.
38. Takenaga, K., Nakamura, Y., and Sakiyama, S. Expression of antisense RNA to S100A4 gene encoding a S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene, 14: 331-337, 1997.
39. Nakagawa, T., Kubota, T., Kabuto, M., Fujimot, N., and Okada, Y. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by recombinant glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix. J. Neuro-oncol., 28: 13-24, 1996.
40. Grigioni, W. F., Derrico, A., Fiorentino, M., Baccarini, P., Onisto, M., Caeazzo, C. Stetler-Stevenson, W. G., Garbisa, S., and Mancini, A. M. Gelatinase A (MMP-2) and its mRNA detected in both neoplastic and stromal cells of tumors with different invasive and metastatic properties. Diagn. Mol. Path., 3: 163-169, 1994.
41. Garbisa, S., Scagliotti, G., Masiero, L., Di Francesco, C., Caenazzo, C., Onisto, M., Micela, M., Stetler-Stevenson, W. G., and Liotta, L. A. Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. Cancer Res., 52: 4548-4549, 1992.
42. Gohij, K., Fujimoto, N., Fuji, A., Komiyama, T., Okawa, J., and Nakajima, M. Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinase-2 in recurrence of urothelial cancer after complete resection. Cancer Res., 56: 3196-3198, 1996.
43. DeClerk, Y., Yean, T. D., Chan, D., Shimada, H., and Langley, K. E. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res., 51: 2151-2157, 1991.
44. Imren, S., Kohn, D. B., Shimada, H., Blavier, L., and DeClerck, Y. A. Overexpression of tissue inhibitor of metalloproteinase-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res., 56: 2891-2895, 1996.
45. Albini, A., Melchoiri, A., Santi, L., Liotta, L. A., Brown, P. D., and Stetler-Stevenson, W. G. Tumor cell invasion inhibited by TIMP-2. J. Natl. Cancer Inst., 83: 775-779, 1991.
46. Yu, A. E., Hewitt, R. E., Kleiner, D. E., and Stetler-Stevenson, W. G. Molecular regulation of cellular invasion-role of gelatinase A and TIMP-2. Biochem. Cell Biol., 74: 821-823, 1996.
47. Kossakowa, A. E., Huchcroft, S. A., Urbanski, S. J., and Edwards, D. R. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in children. Br. J. Cancer, 73: 1401-1408, 1996.
48. Bjørnland, K., Lehne, G., Johansen, H. T., Fodstad, Ø., Rugstad, H. E., Aasen, A. O., and Ree, A. H. Human hepatoma cells rich in P-glycoprotein display enhanced in vitro invasive properties compared to P-glycoprotein poor hepatoma cells. Oncol. Res., 10: 225-262, 1998.
49. Emmert-Buck, M., Emonard, H. P., Corcoran, M. L., Krutsch, H. C., Foidart, J. M., and Stetler-Stevenson, W. G. Cell surface binding of TIMP-2 and proMMP-2/TIMP-2 complex. FEBS Lett., 364: 28-32, 1995.
50. Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijma, E., and Iwata, K. Growth-promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett., 298: 29-32, 1992.
51. Menashi, S., Dehem, M., Souliac, I., Legrand, Y., and Fridman, R. Density-dependent regulation of cell-surface association of matrix metalloproteinase-2 (MMP-2) in breast-carcinoma cells. Int. J. Cancer, 75: 259-265, 1998.
52. Llorens, A., Rodrigo, I., Lopez-Barons, L., Gonzales-Garrigues, M., Lozano, E., Vinyals, A., Qiuntanilla, M., Cano, A., and Fabra, A. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. Lab. Invest., 78: 1131-1142, 1998.
53. Silletti, S., Yao, J. P., Pienta, K. J., and Raz, A. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells. Int. J. Cancer, 63: 100-105, 1995.
54. Ess, K., Chen, H., Kier, A., and Brackenbury, R. Suppression of tumorigenicity, but not invasion, in glioblastoma/HeLa cell hybrids. J. Cell. Physiol., 162: 341-347, 1995.
55. Sieuwerts, A. M., Klijn, J. G., and Foekens, J. A. Assessment of invasive potential of human gynecological tumor cell lines with in vitro Boyden chamber assay: influences of the ability of cells to migrate through the filter membrane. Clin. Exp. Metastasis, 15: 53-62; 1997.
56. Coopman, P. J., Do, M. T., Thompson, E. W., and Mueller, S. C. Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin. Cancer Res., 4: 507-515, 1998.